—

Medacta Group SA (MOVE.SW) — the peer cohort

As of 2026-10-15 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Medacta Group SA ranks 10 of 10 in its cohort on the Closelooknet composite (48/100) — the cohort is led by DexCom Inc at 66/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
MOVE.SW Medacta Group SA 48 14 57 30 warn 34.4%
DXCM DexCom Inc 66 87 80 34 watch 9.8%
GMED Globus Medical 60 37 64 57 bear 24.7%
SECT-B.ST Sectra AB (publ) 60 83 66 11 watch 6.4%
SNN Smith & Nephew SNATS Inc 57 30 55 73 info 21.3%
CEVI.ST CellaVision AB 55 71 69 29 bull 12.6%
SYK Stryker Corporation 52 27 66 43 bear 27.9%
YPSN.SW Ypsomed Holding AG 56 75 62 28 info 9.5%
BANB.SW Bachem Holding AG 51 85 40 32 ok 0%
TECN.SW Tecan Group AG 49 96 27 52 ok 3.6%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-15

Quick answers

Who are Medacta Group SA's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: DexCom Inc (DXCM), Globus Medical (GMED), Sectra AB (publ) (SECT-B.ST), Smith & Nephew SNATS Inc (SNN), CellaVision AB (CEVI.ST), Stryker Corporation (SYK), Ypsomed Holding AG (YPSN.SW), Bachem Holding AG (BANB.SW) and others.

How does MOVE.SW score against its peers?

Medacta Group SA's composite reads 48/100, ranking 10 of 10 in its cohort as of 2026-10-15; the cohort's highest composite is DexCom Inc at 66/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.